Medical Device and Diagnostic Industry (MD+DI)

Edwards Lifesciences Wins FDA Approval for First Tricuspid Surgical Valve Replacement

Edwards Lifesciences gains FDA approval for Triformis Resilia, the first surgical valve for tricuspid disease, potentially ...
Medical Design & Outsourcing

Edwards Lifesciences makes a simple change for a first-of-its-kind tricuspid valve

The Edwards Triformis Resilia is the first surgical valve designed and approved for the tricuspid position, thanks to a small ...
Barchart on MSN

Is Edwards Lifesciences stock underperforming the Nasdaq?

With a market cap of $50.5 billion, Edwards Lifesciences Corporation (EW) is a leading medical technology company ...
Business Wire

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.
Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
MM&M

Edwards Lifesciences debuts heart valve failure PSA as Rams training camp begins

Training camp is underway for the Los Angeles Rams and so is the latest awareness push from one of the franchise’s healthcare partners, Edwards Lifesciences. The medtech company unveiled the full ...
Hosted on MSN

Edwards Lifesciences Gains Ground After Rival Exits Valve Market

Edwards Lifesciences (NYSE:EW) saw its shares rise by 3% following news that competitor Boston Scientific (NYSE:BSX) is exiting the aortic valve market. Boston Scientific announced it will cease ...
Nasdaq

Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System Wins FDA Approval

(RTTNews) - Edwards Lifesciences Corp. (EW) on Tuesday said its SAPIEN M3 mitral valve replacement system received U.S. Food and Drug Administration (FDA) approval for the treatment of mitral ...